The biotechnology industry is coming into its own, according to Beyond Borders, Ernst & Young's 19th Annual Global Biotechnology report. With governmental support and private capital, biotech companies worldwide are translating cutting-edge science into life-improving therapies. The industry's success in 2004 included:
"Biotech innovation is a key value driver for the pharmaceutical industry, as more than half of its late-stage pipeline now consists of therapeutics generated using biotechnology advances," said Mike Hildreth, Americas director, biotechnology, Ernst &Young.
One study linked multiple pregnancies to an increased risk of developing atrial fibrillation later in life, and another investigated the association between premature delivery and cardiovascular disease.
Clinical features with downloadable PDFs